Featuring a slide presentation and related discussion from Prof Sia Daneshmand, including the following topics:
- Continuous intravesical drug delivery for patients with muscle-invasive urothelial bladder cancer (MIBC) (0:00)
- Current role of checkpoint inhibitors alone or in combination with chemotherapy for urothelial bladder cancer (UBC) (9:26)
- Emerging data with novel agents and strategies for the management of UBC (14:52)
- Case: A man in his mid 70s with a history of high-grade T1 disease who is not a good candidate for cystectomy (18:57)
- Case: A man in his early 80s with high-grade T2 MIBC who is not a candidate for cystectomy or neoadjuvant chemotherapy (22:27)
- Case: A woman in her late 50s with completely resected UBC with a strong preference for bladder-sparing treatment (24:43)
CME information and select publications
Research To Practice | Oncology Videos